Legacy Wealth Management (Idaho)’s CollPlant Biotechnologies CLGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.4K Buy
23,179
+19,707
+568% +$19.9K 0.01% 447
2025
Q4
$4.86K Buy
+3,472
New +$7.11K ﹤0.01% 538

Other funds holding CLGN

Legacy Wealth Management (Idaho)'s CLGN Position: Q1 2026 in Review

Legacy Wealth Management (Idaho) increased its CollPlant Biotechnologies (CLGN) stake by 568% in Q1 2026, buying an estimated $19.9K and bringing the position to 23,179 shares worth $12.4K. The position accounts for 0.01% of the portfolio, ranked #447.

Legacy Wealth Management (Idaho) first reported a position in CLGN in Q4 2025 and has held it in 2 quarters since. 21 funds tracked by Wall St. Rank hold CLGN as of Q1 2026.

  • Legacy Wealth Management (Idaho) held 23,179 shares of CollPlant Biotechnologies worth $12.4K as of Q1 2026.
  • Legacy Wealth Management (Idaho) bought 19,707 CollPlant Biotechnologies shares in Q1 2026, an estimated $19.9K.
  • CollPlant Biotechnologies made up 0.01% of Legacy Wealth Management (Idaho)'s portfolio in Q1 2026, its #447 holding.
  • Legacy Wealth Management (Idaho) first reported a position in CollPlant Biotechnologies in Q4 2025 and has held it in 2 quarters since.
  • 21 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q1 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q1 2026, filed 7 May 2026.